Custom Gene Therapy for Hemophilia: Service by Thermo Fisher

T&L Biotechnology Co., Ltd. is at the forefront of innovation with its groundbreaking gene therapy designed specifically for hemophilia treatment. This advanced therapy addresses the root cause of hemophilia by delivering functional copies of the defective gene responsible for clotting factor deficiencies. By using a safe and effective viral vector, our therapy allows for the sustained production of essential clotting factors, which significantly reduces bleeding episodes and improves the quality of life for patients